A detailed history of Kanawha Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Kanawha Capital Management LLC holds 2,280 shares of LLY stock, worth $1.8 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
2,280
Previous 2,082 9.51%
Holding current value
$1.8 Million
Previous $1.89 Million 7.11%
% of portfolio
0.16%
Previous 0.16%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$772.14 - $960.02 $152,883 - $190,083
198 Added 9.51%
2,280 $2.02 Million
Q2 2024

Jul 25, 2024

BUY
$724.87 - $909.04 $531,329 - $666,326
733 Added 54.34%
2,082 $1.89 Million
Q1 2024

Apr 29, 2024

BUY
$592.2 - $792.28 $43,822 - $58,628
74 Added 5.8%
1,349 $1.05 Million
Q4 2023

Jan 29, 2024

BUY
$525.19 - $619.13 $13,129 - $15,478
25 Added 2.0%
1,275 $743,000
Q3 2023

Oct 26, 2023

SELL
$434.7 - $599.3 $47,817 - $65,923
-110 Reduced 8.09%
1,250 $671,000
Q2 2023

Jul 28, 2023

BUY
$350.74 - $468.98 $3,156 - $4,220
9 Added 0.67%
1,360 $637,000
Q1 2023

May 08, 2023

SELL
$310.63 - $364.82 $15,220 - $17,876
-49 Reduced 3.5%
1,351 $463,000
Q4 2022

Feb 01, 2023

BUY
$321.55 - $374.67 $39,550 - $46,084
123 Added 9.63%
1,400 $512,000
Q3 2022

Oct 31, 2022

SELL
$296.48 - $337.87 $14,824 - $16,893
-50 Reduced 3.77%
1,277 $413,000
Q2 2022

Jul 27, 2022

BUY
$278.73 - $327.27 $16,166 - $18,981
58 Added 4.57%
1,327 $430,000
Q4 2021

Jan 31, 2022

BUY
$224.85 - $279.04 $21,135 - $26,229
94 Added 8.0%
1,269 $350,000
Q3 2021

Oct 28, 2021

SELL
$221.6 - $272.71 $21,052 - $25,907
-95 Reduced 7.48%
1,175 $271,000
Q2 2021

Jul 22, 2021

SELL
$180.55 - $233.54 $2,708 - $3,503
-15 Reduced 1.17%
1,270 $291,000
Q1 2021

Apr 26, 2021

BUY
$164.32 - $212.72 $10,680 - $13,826
65 Added 5.33%
1,285 $240,000
Q4 2020

Feb 01, 2021

BUY
$130.46 - $172.63 $159,161 - $210,608
1,220 New
1,220 $206,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Kanawha Capital Management LLC Portfolio

Follow Kanawha Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kanawha Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kanawha Capital Management LLC with notifications on news.